Clinical Trial Update: Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intensive chemo-immunotherapy as first-line treatment in adults with peripheral T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Lymphoma, T-Cell, Peripheral | Phase 2 | Status: COMPLETED